Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-01-11
2011-01-11
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S357000
Reexamination Certificate
active
07868006
ABSTRACT:
The present application discloses a compound, or enantiomers, stereoisomers, rotamers, tautomers, racemates or prodrug of said compound, or pharmaceutically acceptable salts, solvates or esters of said compound, or of said prodrug, said compound having the general structure shown in Formula 1:or a pharmaceutically acceptable salt, solvate or ester thereof, wherein the various moieties are defined herein. Also disclosed is a method of treating chemokine mediated diseases, such as, palliative therapy, curative therapy, prophylactic therapy of certain diseases and conditions such as inflammatory diseases (non-limiting example(s) include, psoriasis), autoimmune diseases (non-limiting example(s) include, rheumatoid arthritis, multiple sclerosis), graft rejection (non-limiting example(s) include, allograft rejection, xenograft rejection), infectious diseases (e.g, tuberculoid leprosy), fixed drug eruptions, cutaneous delayed-type hypersensitivity responses, ophthalmic inflammation, type I diabetes, viral meningitis and tumors using a compound of Formula 1.
REFERENCES:
patent: 6124319 (2000-09-01), MacCoss et al.
patent: 6794379 (2004-09-01), Medina et al.
patent: 7417045 (2008-08-01), Anilkumar et al.
patent: 7566718 (2009-07-01), Wong et al.
patent: 2002/0018776 (2002-02-01), Hancock
patent: 2003/0055054 (2003-03-01), Medina et al.
patent: 2006/0276448 (2006-12-01), Zeng et al.
patent: 2006/0276457 (2006-12-01), Yu et al.
patent: 2007/0021611 (2007-01-01), McGuinness et al.
patent: 2007/0054919 (2007-03-01), Rosenblum et al.
patent: 2007/0082913 (2007-04-01), Kim et al.
patent: 2008/0039474 (2008-02-01), Rosenblum et al.
patent: 2008/0058343 (2008-03-01), Rosenblum et al.
patent: 2008/0292589 (2008-11-01), Anilkumar et al.
patent: WO93/10091 (1993-05-01), None
patent: WO 93/14077 (1993-07-01), None
patent: WO99/20606 (1999-04-01), None
patent: WO03/070242 (2001-08-01), None
patent: WO02/085861 (2001-10-01), None
patent: WO03/082335 (2003-10-01), None
patent: WO03/098185 (2003-11-01), None
patent: WO03/101970 (2003-12-01), None
patent: WO2004/074278 (2004-09-01), None
patent: WO2004/074287 (2004-09-01), None
patent: WO 2004/113323 (2004-12-01), None
patent: WO2008/079279 (2008-07-01), None
Dorwald F. A. Side Reactions in Organic Synthesis, 2005, Wiley: VCH, Weinheim p. IX of Preface.
Vippagunta et. al. Advanced Drug Delivery Reviews 48 (2001) 3-26.
International Search Report, International app. No. PCT/US2006/005123, International filing date: Feb. 14, 2006 (mail date: Aug. 4, 2006).
Qingbei Zeng et al., U.S. Appl. No. 12/519,970; Preliminary Amendment—Mailed Jun. 18, 2009.
Notice of Allowance in U.S. Appl. No. 11/545,201 mailed Nov. 17, 2009.
Notice of Allowance in U.S. Appl. No. 11/353,697 mailed Jan. 7, 2010.
Notice of Allowance in U.S. Appl. No. 11/688,014 mailed Jan. 19, 2010.
Anilkumar Gopinadhan N.
Hobbs Douglas W.
Kim Seong Heon
Kozlowski Joseph A.
McGuinness Brian F.
Banerjee Krishna G.
Kalyanaraman Palaiyur
Meade Eric A.
Murray Jeffrey H
Pharmacopeia Drug Discovery Inc.
LandOfFree
Heterocyclic substituted piperazines with CXCR3 antagonist... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic substituted piperazines with CXCR3 antagonist..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic substituted piperazines with CXCR3 antagonist... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2727361